Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China flag China · Delayed Price · Currency is CNY
15.24
-0.44 (-2.81%)
At close: Nov 13, 2026

SHE:301246 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
649.93472.74745.59421.86395.19120.43
Short-Term Investments
-258.4379.25292.3190-
Trading Asset Securities
1,0291,128900.321,466--
Cash & Short-Term Investments
1,6791,8592,0252,180485.19120.43
Cash Growth
22.76%-8.19%-7.10%349.31%302.89%-55.02%
Accounts Receivable
789.25904.42559.44602.64660.21458.16
Other Receivables
59.2446.779.89141.6787.645.85
Receivables
848.49951.12639.33744.3747.8504.01
Inventory
316.15319.01270.53191.51352.95384.48
Prepaid Expenses
-0.230.05---
Other Current Assets
341.19167.23111.2986.4378.9820.72
Total Current Assets
3,1853,2973,0463,2021,6651,030
Property, Plant & Equipment
2,6192,3642,2921,9101,620891.27
Long-Term Investments
219.45211.24203.64228.08335.12242.35
Other Intangible Assets
174.74178.84181.89183.06173.62194.15
Long-Term Deferred Tax Assets
19.3119.6617.2617.5621.2217.72
Long-Term Deferred Charges
3.364.085.525.956.8611.98
Other Long-Term Assets
219.6989.5978.06103.953.2745.14
Total Assets
6,4406,1655,8255,6513,8752,432

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
905.75798.99777.27636.79934.95340.92
Accrued Expenses
14.8163.6455.2857.5465.757.98
Short-Term Debt
78.8360.0459.32-17.6420.1
Current Portion of Long-Term Debt
113.495.8277.0165.966.092.84
Current Portion of Leases
-0.750.740.60.560.53
Current Income Taxes Payable
9.1623.073.561.1538.2945.65
Current Unearned Revenue
19.719.7913.8719.831.0129.66
Other Current Liabilities
100.2179.11148.94133.04165.66120.05
Total Current Liabilities
1,2421,2411,136914.831,320617.73
Long-Term Debt
467.51368.34230.36276.12341.6747.22
Long-Term Leases
6.296.427.166.98.198.23
Long-Term Unearned Revenue
64.368.0868.6471.5570.4560.8
Long-Term Deferred Tax Liabilities
21.0821.7321.6221.5421.3120.3
Total Liabilities
1,8011,7061,4641,2911,762754.27

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
400.01400.01400.01400.01352.75352.75
Additional Paid-In Capital
2,1852,1772,1722,17222.1520.62
Retained Earnings
2,0891,9251,8181,7861,7391,304
Treasury Stock
-40.34-47.15-32.8---
Comprehensive Income & Other
6.914.973.371.8900.46
Total Common Equity
4,6414,4604,3614,3602,1141,678
Minority Interest
-1.82-0.730.47---
Shareholders' Equity
4,6394,4594,3614,3602,1141,678
Total Liabilities & Equity
6,4406,1655,8255,6513,8752,432

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
666.04531.36374.59349.51434.1478.92
Net Cash (Debt)
1,0131,3281,6511,83151.0541.51
Net Cash Growth
41.17%-19.55%-9.83%3485.91%22.99%-62.14%
Net Cash Per Share
2.533.354.144.720.140.12
Filing Date Shares Outstanding
396.81396.81396.81399.9400.01352.75
Total Common Shares Outstanding
396.81396.81397.89400.01352.75352.75
Working Capital
1,9432,0561,9102,287345.02411.91
Book Value Per Share
11.7011.2410.9610.905.994.76
Tangible Book Value
4,4664,2814,1794,1771,9401,484
Tangible Book Value Per Share
11.2610.7910.5010.445.504.21
Buildings
-883.32833.02719.62395.96329.31
Machinery
-1,8341,6491,470782.58657
Construction In Progress
-598.72630.57375.86946.39334.11